Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality.

Rohan VS, McGillicuddy JW, Taber DJ, Nadig SN, Baliga PK, Bratton CF.

Clin Transplant. 2019 Aug 17:e13695. doi: 10.1111/ctr.13695. [Epub ahead of print]

PMID:
31421062
2.

Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

Patel KJ, Cheng Q, Stephenson S, Allen DP, Li C, Kilkenny J, Finnegan R, Montalvo-Calero V, Esckilsen S, Vasu C, Goddard M, Nadig SN, Atkinson C.

Am J Respir Cell Mol Biol. 2019 Jun;60(6):678-686. doi: 10.1165/rcmb.2018-0224OC.

PMID:
30571141
3.

Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo.

Zhu P, Atkinson C, Dixit S, Cheng Q, Tran D, Patel K, Jiang YL, Esckilsen S, Miller K, Bazzle G, Allen P, Moore A, Broome AM, Nadig SN.

RSC Adv. 2018 Jul 23;8(46):25909-25919. doi: 10.1039/c8ra01555d.

4.

"Mirror, Mirror on the Wall"… Pediatric liver transplantation in the case of situs inversus totalis with a disrupted inferior vena cava.

Edgerton CA, Gross M, Kasi N, Hewitt W, Edmondson S, Rohan VS, Nadig SN.

Pediatr Transplant. 2018 Aug;22(5):e13218. doi: 10.1111/petr.13218. Epub 2018 May 15.

PMID:
29761937
5.

HDAC inhibition helps post-MI healing by modulating macrophage polarization.

Kimbrough D, Wang SH, Wright LH, Mani SK, Kasiganesan H, LaRue AC, Cheng Q, Nadig SN, Atkinson C, Menick DR.

J Mol Cell Cardiol. 2018 Jun;119:51-63. doi: 10.1016/j.yjmcc.2018.04.011. Epub 2018 Apr 19.

6.

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology.

Arbra CA, Nadig SN, Dennis SG, Pattanaik S, Bainbridge HA, Rhett JM, Fann SA, Atkinson C, Yost MJ.

J Vis Exp. 2018 Mar 27;(133). doi: 10.3791/57358.

7.

Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation.

Tran DT, Esckilsen S, Mulligan J, Mehrotra S, Atkinson C, Nadig SN.

Transplantation. 2018 Jun;102(6):935-944. doi: 10.1097/TP.0000000000002163.

8.

Combined Endoscopic-Percutaneous Biliary Restoration Following Severe Bile Duct Injury During Cholecystectomy.

Elmunzer JB, Feussner DJ, Payne MK, Nadig SN, Yamada R.

Am J Gastroenterol. 2018 Mar;113(3):328. doi: 10.1038/ajg.2017.504. No abstract available.

PMID:
29535441
9.

Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.

Cheng Q, Patel K, Lei B, Rucker L, Allen DP, Zhu P, Vasu C, Martins PN, Goddard M, Nadig SN, Atkinson C.

Am J Transplant. 2018 Oct;18(10):2417-2428. doi: 10.1111/ajt.14717. Epub 2018 Apr 10.

10.

Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients.

Arms MA, Fleming J, Sangani DB, Nadig SN, McGillicuddy JW, Taber DJ.

Surgery. 2018 Feb;163(2):430-435. doi: 10.1016/j.surg.2017.09.027. Epub 2017 Nov 22.

11.

Nanotechnological Approaches to Immunosuppression and Tolerance Induction.

Patel K, Atkinson C, Tran D, Nadig SN.

Curr Transplant Rep. 2017 Jun;4(2):159-168. doi: 10.1007/s40472-017-0146-9. Epub 2017 Apr 17.

12.

Utilization of the Iliac Artery as Inflow in the Morbidly Obese During Orthotopic Liver Transplantation: A Case Report.

Edgerton CA, McGillicuddy JW, DuBay D, Nadig SN.

Transplant Proc. 2017 Sep;49(7):1624-1627. doi: 10.1016/j.transproceed.2017.05.004.

PMID:
28838452
13.

Use of intra-aortic counterpulsation in cardiogenic shock post-liver transplantation.

Palanisamy AP, Nadig SN, Chedister GR, Dowden JE, Koch DG, Stoll WD, McGillicuddy JW, Chavin KD.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.13002. Epub 2017 Jun 5. Review.

PMID:
28489254
14.

Transplant Arteriosclerosis.

Nadig SN.

Transplantation. 2016 Nov;100(11):2249-2250. No abstract available.

PMID:
27495767
15.

Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients.

Jordan CL, Taber DJ, Kyle MO, Connelly J, Pilch NW, Fleming J, Meadows HB, Bratton CF, Nadig SN, McGillicuddy JW, Chavin KD, Baliga PK, Shatat IF, Twombley K.

Pediatr Transplant. 2016 Feb;20(1):44-8. doi: 10.1111/petr.12625. Epub 2015 Nov 18.

PMID:
26576516
16.

A simplified cuff technique for abdominal aortic transplantation in mice.

Zhu P, Esckilsen S, Atkinson C, Chen XP, Nadig SN.

J Surg Res. 2016 Feb;200(2):707-13. doi: 10.1016/j.jss.2015.08.039. Epub 2015 Aug 28.

17.

Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity.

Nadig SN, Dixit SK, Levey N, Esckilsen S, Miller K, Dennis W, Atkinson C, Broome AM.

RSC Adv. 2015;5(54):43552-43562. doi: 10.1039/C5RA04057D. Epub 2015 Apr 24.

18.

Internal biliary stenting during orthotopic liver transplantation: anastomotic complications, post-transplant biliary interventions, and survival.

Mathur AK, Nadig SN, Kingman S, Lee D, Kinkade K, Sonnenday CJ, Welling TH.

Clin Transplant. 2015 Apr;29(4):327-35. doi: 10.1111/ctr.12518. Epub 2015 Feb 23.

19.

Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients.

Palanisamy AP, Al Manasra AR, Pilch NA, Dowden JE, Nadig SN, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ.

Clin Transplant. 2015 Mar;29(3):222-6. doi: 10.1111/ctr.12507. Epub 2015 Jan 27.

PMID:
25557762
20.

Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis.

Palanisamy AP, Taber DJ, Sutter AG, Nadig SN, Dowden JE, McGillicuddy JW, Baliga PK, Chavin KD.

J Gastrointest Surg. 2015 Feb;19(2):282-9. doi: 10.1007/s11605-014-2675-1. Epub 2014 Oct 16.

21.

Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis.

Palanisamy AP, Schiltz CE 3rd, Pilch NA, Hunt KJ, Nadig SN, Dowden JE, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ.

Blood Press. 2015 Feb;24(1):14-22. doi: 10.3109/08037051.2014.934527. Epub 2014 Jul 22.

PMID:
25048253
22.

Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group.

Mellinger JL, Rossaro L, Naugler WE, Nadig SN, Appelman H, Lee WM, Fontana RJ.

Dig Dis Sci. 2014 Jul;59(7):1630-7. doi: 10.1007/s10620-014-3029-2. Epub 2014 Jan 25. Review.

23.

Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.

Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, Hughes S, Johnson P, Wood KJ.

Transplantation. 2013 Oct 27;96(8):707-16. doi: 10.1097/TP.0b013e31829fa271.

24.

Preoperative medication management: filling in the gaps.

Nadig SN, Wright Nunes JA.

South Med J. 2013 Aug;106(8):447-8. doi: 10.1097/SMJ.0b013e3182a05875. No abstract available.

PMID:
23912136
25.

A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years.

Pelletier SJ, Nadig SN, Lee DD, Ammori JB, Englesbe MJ, Sung RS, Magee JC, Fontana RJ, Punch JD.

HPB (Oxford). 2013 Apr;15(4):286-93. doi: 10.1111/j.1477-2574.2012.00576.x. Epub 2012 Sep 28.

26.

Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.

Schiopu A, Nadig SN, Cotoi OS, Hester J, van Rooijen N, Wood KJ.

Atherosclerosis. 2012 Aug;223(2):291-8. doi: 10.1016/j.atherosclerosis.2012.05.010. Epub 2012 May 19.

27.

Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.

Hester J, Schiopu A, Nadig SN, Wood KJ.

Am J Transplant. 2012 Aug;12(8):2008-16. doi: 10.1111/j.1600-6143.2012.04065.x. Epub 2012 Apr 14.

28.

Clinical implications of mucinous nonneoplastic cysts of the pancreas.

Nadig SN, Pedrosa I, Goldsmith JD, Callery MP, Vollmer CM.

Pancreas. 2012 Apr;41(3):441-6. doi: 10.1097/MPA.0b013e318229b9b8.

PMID:
22015974
29.

Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.

Feng G, Nadig SN, Bäckdahl L, Beck S, Francis RS, Schiopu A, Whatcott A, Wood KJ, Bushell A.

Sci Transl Med. 2011 May 18;3(83):83ra40. doi: 10.1126/scitranslmed.3002099.

30.

Living donor kidney transplantation at the University of Michigan.

Lee DD, Gooden CW, Nadig SN, Sonnenday CJ, Abbott C, Magee JC, Englesbe MJ, Punch JD, Samaniego M, Merion RM, Sung RS.

Clin Transpl. 2011:77-89.

PMID:
22755404
31.

Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.

Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K.

Transplantation. 2010 Dec 27;90(12):1321-7. doi: 10.1097/TP.0b013e3181ff8772.

32.

In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.

Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, Luo S, Schiopu A, Taggart DP, Wood KJ.

Nat Med. 2010 Jul;16(7):809-13. doi: 10.1038/nm.2154. Epub 2010 May 16.

33.

CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.

Warnecke G, Feng G, Goto R, Nadig SN, Francis R, Wood KJ, Bushell A.

Am J Pathol. 2010 Jul;177(1):464-72. doi: 10.2353/ajpath.2010.090292. Epub 2010 May 14.

34.

Transplantation tolerance: lessons from experimental rodent models.

Kingsley CI, Nadig SN, Wood KJ.

Transpl Int. 2007 Oct;20(10):828-41. Epub 2007 Aug 17. Review.

35.

Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo.

Warnecke G, Bushell A, Nadig SN, Wood KJ.

Transplantation. 2007 Jun 15;83(11):1459-65.

PMID:
17565319
36.

Marginal donors in liver transplantation: expanding the donor pool.

Nadig SN, Bratton CF, Karp SJ.

J Surg Educ. 2007 Jan-Feb;64(1):46-50. No abstract available.

PMID:
17320806
37.

Hepatocellular ultrastructure after ischemia/reperfusion injury in human orthotopic liver transplantation.

Nadig SN, Periyasamy B, Shafizadeh SF, Polito C, Fiorini RN, Rodwell D, Evans Z, Cheng G, Dunkelberger D, Schmidt M, Self SE, Chavin KD.

J Gastrointest Surg. 2004 Sep-Oct;8(6):695-700.

PMID:
15358330
38.

"Drowned lung" following lobectomy and radiation therapy: a case report.

Nadig SN, Block MI.

J S C Med Assoc. 2003 Feb;99(2):26-9.

PMID:
12664823
39.

Intrarenal varix presenting as an enhancing renal mass with calcifications.

Deibler AR, Nadig SN, Curry N, Bissada NK, Hull GW.

J Urol. 2001 Sep;166(3):997-8. No abstract available.

PMID:
11490273
40.

Small cell carcinoma of the prostate: an underrecognized entity.

Nadig SN, Deibler AR, El Salamony TM, Hull GW, Bissada NK.

Can J Urol. 2001 Feb;8(1):1207-10.

PMID:
11268310
41.

Retained needle fragments in patients with diabetic neuropathy.

Nadig SN, Deibler AR, Marlow T, Wiley MK, Schabel SI.

JAMA. 2000 Jun 21;283(23):3072. No abstract available.

PMID:
10865298

Supplemental Content

Loading ...
Support Center